by Vora Corporate Finance | Feb 24, 2024 | Insights
Economic Update: Finance and Corporate Affairs Minister Smt. Nirmala Sitharaman presented the Interim Union Budget for 2024-25 in the parliament. Finance minister highlighted that Indian economy has demonstrated resilience and maintained healthy macro-economic...
by Vora Corporate Finance | Feb 24, 2024 | Insights, Private Equity & IPO
PE: PlasmaGen Biosciences Raises $27 Million in Series C round. Transaction: Plasmagen Biosciences, a biopharmaceutical company focused on blood plasma-derived pharmaceutical products for India and emerging markets, has raised INR 225 crores, led by UK based Artian...
by Vora Corporate Finance | Feb 24, 2024 | Insights, Merger & Acquisitions
M&A: Max Healthcare acquires Sahara Hospital, Lucknow at an Enterprise Value of Rs 940 Crores. Transaction: Max Health said it was acquiring a 100% stake in 550 Bedded Sahara Hospital at an enterprise value of Rs 940 Crore, representing an enterprise value/sales...
by Vora Corporate Finance | Feb 24, 2024 | Insights
Secondary Market: The Indian stock markets continued their rally with substantial gains at Nifty 50 and Sensex gaining 7.94% at 21,731.40 and 7.84% at 72,240.26 respectively. The Nifty Index finished the year with a gain of 20.03%, experiencing a remarkable surge of...
by Vora Corporate Finance | Feb 24, 2024 | Insights
Economic Update: The IMF in annual Article IV consultation report acknowledged India’s effective inflation management amidst global commodity price hikes through extensive government interventions. It has projected a balanced outlook for India’s economic...